STRIDEX XL FACE AND BODY PADS- salicylic acid liquid 
Blistex Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Stridex® XL Face & Body Pads™

Drug Facts

Active ingredient

Salicylic acid 2.0% (w/w)

Purpose

Acne medication

Uses

Warnings

For external use only

Allergy alert

do not use this product if you have a known allergy to salicylic acid

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

ammonium lauryl sulfate, ammonium xylenesulfonate, citric acid, citrus grandis (grapefruit) fruit extract, ethylhexylglycerin, fragrances, glycerin, menthol, phenoxyethanol, purified water, simethicone, sodium borate, tetrasodium EDTA

PRINCIPAL DISPLAY PANEL - 90 Pad Jar Carton

✓ Cleans
✓ Treats
✓ Prevents

67% Bigger Pad*

ALCOHOL
FREE

STRIDEX®
SALICYLIC ACID 2% W/W ACNE MEDICATION

XL FACE & BODY PADS™

Max Strength
Medication
+
Pore Tightening
Grapefruit Extract

90 Dual Textured Pads
One Side Scrubbing • One Side Gentle

PRINCIPAL DISPLAY PANEL - 90 Pad Jar Carton
STRIDEX XL FACE AND BODY PADS 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10157-2114
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
water (UNII: 059QF0KO0R)  
sodium borate (UNII: 91MBZ8H3QO)  
.alpha.-chlorohydrin, (+/-)- (UNII: QGS78A3T6P)  
pummelo (UNII: ET1TN5W71X)  
ammonium lauryl sulfate (UNII: Q7AO2R1M0B)  
ammonium xylenesulfonate (UNII: 4FZY6L6XCM)  
citric acid monohydrate (UNII: 2968PHW8QP)  
phenoxyethanol (UNII: HIE492ZZ3T)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)  
silicon dioxide (UNII: ETJ7Z6XBU4)  
edetate sodium (UNII: MP1J8420LU)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10157-2114-11 in 1 CARTON09/20/2020
190 in 1 JAR
12 mL in 1 APPLICATOR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart333D09/20/2020
Labeler - Blistex Inc (005126354)
Establishment
NameAddressID/FEIBusiness Operations
Blistex Inc005126354MANUFACTURE(10157-2114)

Revised: 12/2021
Document Id: 2b3549eb-298e-4ceb-8dfa-548596a03937
Set id: ed459e80-22cc-40ef-862c-1adf82da2377
Version: 2
Effective Time: 20211214
 
Blistex Inc